The Board of UV Flu Technologies, Inc. (OTCPK:UVFT) announced the spin-off of RxAir Industries, LLC on June 21, 2013. The transaction will be structured as a pro rata distribution to all shareholders of UV Flu Technologies an additional common stock in RxAir Industries. Pursuant to completion on transaction RxAir Industries will trade as a separate publicly-traded entity focusing entirely on the medical and commercial markets while UV Flu Technologies will continue to concentrate on the residential marketplace.

Upon closing of the transaction RxAir Industries will assemble a separate management team and Board of Directors. The transaction was approved by the Board of UV Flu Technologies. The closing of transaction requires further work on structure, management, governance, and other significant matters.

Within the next months, UV Flu Technologies and RxAir Industries management will develop detailed plans for the Board's further consideration and final approval.